Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
pharmaceutical manufacturers in Asia:
Essex Bio-Technology Limited
of Hong Kong
sales of 775.66 million Hong Kong Dollars [US$99.59 million]
of which 94%
was Sales of pharmaceutical products),
Walvax Biotechnology Company Limited
(590.16 million Chinese Renmimbi [US$85.66 million]
of which 38%
was Autonomous Vaccine), and
based in South Korea
(124.19 billion Korean Won [US$110.90 million]
Panacea Biotec Ltd reported sales of 6.53 billion Indian Rupees (US$100.84 million)
March of 2016.
decrease of 5.0%
versus 2015, when the company's sales were 6.87 billion Indian Rupees.
Contributing to the drop in overall sales was the 45.1% decline
in Research and Development, from 238.20 million Indian Rupees to 130.80 million Indian Rupees.
There were also decreases in sales in
Formulation (down 0.1% to 3.87 billion Indian Rupees)
Vaccine (down 8.4% to 2.53 billion Indian Rupees)